543963 — Shelter Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapTurnaround

Annual income statement for Shelter Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Interim Report	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	301	362	400	507	731
Cost of Revenue
Gross Profit	42.1	99	111	136	176
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	272	292	317	409	608
Operating Profit	28.1	69.9	83.4	98	123
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28.1	69.8	82.8	96.8	122
Provision for Income Taxes
Net Income After Taxes	20.6	52.1	62	72.4	90.3
Net Income Before Extraordinary Items
Net Income	20.6	52.1	62	72.4	90.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	20.6	52.1	62	72.4	90.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.78	5.08	5.36	6.26	5.16
Dividends per Share